266 related articles for article (PubMed ID: 6611200)
1. Distinctive phorbol ester-induced morphological and surface antigen changes in mycosis fungoides, the Sézary syndrome, and adult T-cell leukemia.
Kadin ME; Nasu K; Sako D; Su IJ
Cancer Res; 1984 Aug; 44(8):3383-7. PubMed ID: 6611200
[TBL] [Abstract][Full Text] [Related]
2. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
[TBL] [Abstract][Full Text] [Related]
3. Immunopathology of cutaneous T-cell lymphomas.
Nasu K; Said J; Vonderheid E; Olerud J; Sako D; Kadin M
Am J Pathol; 1985 Jun; 119(3):436-47. PubMed ID: 3893149
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells.
Haynes BF; Metzgar RS; Minna JD; Bunn PA
N Engl J Med; 1981 May; 304(22):1319-23. PubMed ID: 6971410
[TBL] [Abstract][Full Text] [Related]
5. Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.
Waldmann TA; Greene WC; Sarin PS; Saxinger C; Blayney DW; Blattner WA; Goldman CK; Bongiovanni K; Sharrow S; Depper JM
J Clin Invest; 1984 Jun; 73(6):1711-8. PubMed ID: 6327770
[TBL] [Abstract][Full Text] [Related]
6. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
[TBL] [Abstract][Full Text] [Related]
7. Phorbol ester-induced differentiation of a non-T/non-B human leukemic cell line (REH) to macrophage-like cells.
Srivastava BI; Koga M; Srivastava P
Cancer Res; 1984 Jul; 44(7):3017-21. PubMed ID: 6373000
[TBL] [Abstract][Full Text] [Related]
8. [Mycosis fungoides and Sézary syndrome: diagnostic and prognostic relevance of cellular antigen expression].
Meissner K; Löning T; Rehpenning W
Hautarzt; 1991 Feb; 42(2):84-91. PubMed ID: 2037492
[TBL] [Abstract][Full Text] [Related]
9. Coexisting Hodgkin's disease and mycosis fungoides. Immunohistochemical proof of its existence.
Simrell CR; Boccia RV; Longo DL; Jaffe ES
Arch Pathol Lab Med; 1986 Nov; 110(11):1029-34. PubMed ID: 3096258
[TBL] [Abstract][Full Text] [Related]
10. Killer cell immunoglobulin-like receptor expression delineates in situ Sézary syndrome lymphocytes.
Wechsler J; Bagot M; Nikolova M; Parolini S; Martin-Garcia N; Boumsell L; Moretta A; Bensussan A
J Pathol; 2003 Jan; 199(1):77-83. PubMed ID: 12474229
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
[TBL] [Abstract][Full Text] [Related]
12. T cells in cutaneous lesions of Sézary syndrome and T-cell leukemia. Characterization by monoclonal antibodies.
Buechner SA; Winkelmann RK; Banks PM
Arch Dermatol; 1983 Nov; 119(11):895-900. PubMed ID: 6227293
[TBL] [Abstract][Full Text] [Related]
13. Alterations in cell surface phenotype of T- and B-cell chronic lymphocytic leukemia cells following in vitro differentiation by phorbol ester.
Shawler DL; Glassy MC; Wormsley SB; Royston I
J Natl Cancer Inst; 1984 May; 72(5):1059-63. PubMed ID: 6609264
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
15. Phorbol ester modulation of T-cell antigens in the Jurkat lymphoblastic leukemia cell line.
Cassel DL; Hoxie JA; Cooper RA
Cancer Res; 1983 Oct; 43(10):4582-6. PubMed ID: 6603901
[TBL] [Abstract][Full Text] [Related]
16. [Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies].
Thivolet J; Schmitt D; Souteyrand P; Brochier J
Nouv Presse Med; 1982 Oct; 11(41):3033-8. PubMed ID: 6755391
[TBL] [Abstract][Full Text] [Related]
17. Phenotype of cells involved in mycosis fungoides and Sézary syndrome (blood and skin lesions): immunomorphological study with monoclonal antibodies.
Schmitt D; Souteyrand P; Brochier J; Czernielewski J; Thivolet J
Acta Derm Venereol; 1982; 62(3):193-9. PubMed ID: 6179357
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody MCS-2 as the marker of phorbol diester-induced myeloid differentiation in acute undifferentiated leukemia.
Gregg SL; Gajl-Peczalska KJ; LeBien TW; Bloomfield CD; Brunning R; Sagawa K
Cancer Res; 1984 Jun; 44(6):2724-30. PubMed ID: 6372996
[TBL] [Abstract][Full Text] [Related]
19. Response of non-T, non-B acute lymphocytic leukemia cells to phorbol ester.
Okamura J; Gelfand EW; Letarte M
Cancer Res; 1984 Mar; 44(3):1246-51. PubMed ID: 6581867
[TBL] [Abstract][Full Text] [Related]
20. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]